A STAT Investigation STAT Plus: How a Texas couple is getting rich off out-of-network medical bills Alla and Scott LaRoque live lavishly, thanks to a business spawned by a federal law designed to protect patients
Exclusive Exclusive March 18, 2026 STAT Plus: FDA’s top infectious disease regulator to depart agency
Politics Politics March 18, 2026 As Trump administration cracks down on health care fraud, people with disabilities feel singled out
Pharmalot Pharmalot March 18, 2026 STAT Plus: A Maryland legislator wants pharma and patient groups to disclose ties to disease awareness campaigns
Biotech Biotech March 18, 2026 STAT Plus: Clearing tumors in mice, Azalea Therapeutics advances dream of in vivo CAR-T therapy
First Opinion Semaglutide is going off-patent in India. But will people who need it be able to get it?
Politics STAT Plus: NIH will spend its full budget this year, agency director promises House appropriators
Politics STAT Plus: NIH grant awards are again lagging far behind historical averages, analysis shows
Politics STAT Plus: FDA and NIH announce more initiatives to reduce animal testing in drug development
STAT Plus: White House digs in on ‘most-favored nation’ drug pricing despite Congress’ cool reception
Health Health March 18, 2026 More than 150,000 uncounted Covid-19 deaths occurred early in the pandemic, a study finds
AI Prognosis AI Prognosis March 18, 2026 STAT Plus: How ARPA-H is developing FDA-authorized AI agents, tested in clinical trials
Politics Politics March 18, 2026 STAT Plus: FDA and NIH announce more initiatives to reduce animal testing in drug development
First Opinion First Opinion March 18, 2026 I was a surgeon. The hardest part of leaving medicine was believing that I could
Health Health March 18, 2026 Drug smoking can lead to severe burns, complicating harm reduction efforts
Politics Politics March 17, 2026 STAT Plus: NIH will spend its full budget this year, agency director promises House appropriators
Exclusive Exclusive March 17, 2026 STAT Plus: VC firm Dimension scouting out $700 million for new fund
D.C. Diagnosis D.C. Diagnosis March 17, 2026 STAT Plus: Judge deals blow to RFK Jr.’s vaccine reforms
Pharmalot Pharmalot March 18, 2026 STAT Plus: A Maryland legislator wants pharma and patient groups to disclose ties to disease awareness campaigns
Biotech Biotech March 18, 2026 STAT Plus: Clearing tumors in mice, Azalea Therapeutics advances dream of in vivo CAR-T therapy
Exclusive Exclusive March 18, 2026 STAT Plus: FDA’s top infectious disease regulator to depart agency
Exclusive Exclusive March 11, 2026 STAT Plus: A top biotech VC quietly helped Epstein’s ‘great friend’ make a comeback
Pharmalot Pharmalot March 18, 2026 STAT Plus: Pharmalittle: We’re reading about TrumpRx prices, a J&J psoriasis pill, and much more
The Readout The Readout March 17, 2026 STAT Plus: Senator blasts GSK inhaler practices, calls for reform
Health Tech Newsletter Health Tech Newsletter March 17, 2026 STAT Plus: Epic notches a legal win, but the saga continues
Pharmalot Pharmalot March 17, 2026 STAT Plus: Pharmalittle: We’re reading about Trump’s drug pricing moves, a GSK asthma drug, and more
Politics Politics March 17, 2026 STAT Plus: White House digs in on ‘most-favored nation’ drug pricing despite Congress’ cool reception
Health tech Health tech March 17, 2026 STAT Plus: For decades, they’ve set the record straight in biology. Next up: science’s reproducibility crisis
First Opinion First Opinion March 18, 2026 I was a surgeon. The hardest part of leaving medicine was believing that I could
First Opinion First Opinion March 17, 2026 The greatest threat to federally qualified health centers may not be federal funding cuts
First Opinion First Opinion March 17, 2026 Semaglutide is going off-patent in India. But will people who need it be able to get it?
Opinions+ Opinions+ March 16, 2026 Congress must pass legislation to ensure Medicare covers breakthrough medical technologies
First Opinion First Opinion March 16, 2026 I have a genetic mutation linked to ALS. The Trump administration terrifies me
Biotech Biotech March 16, 2026 STAT Plus: Structure Therapeutics reports significant weight loss from mid-stage GLP-1 pill
Biotech Biotech March 12, 2026 STAT Plus: Is Aldeyra Therapeutics waving red flags with consequences?
Pharmalot Pharmalot March 16, 2026 STAT Plus: Asthma patients suffered as GSK pursued ‘egregious’ price hikes, senator says
Pharmalot Pharmalot March 16, 2026 STAT Plus: Pharmalittle: We’re reading about obesity pill trial results, cholesterol guidelines, and more
Health Health March 17, 2026 Smoking rates are at a historic low. You’re not hearing about it from the government
Health Health March 16, 2026 Federal judge stalls health secretary RFK Jr.’s overhaul of vaccine policy
Health Health March 16, 2026 STAT Plus: New technologies promise to transform organ transplantation. But when?
Politics Politics March 13, 2026 STAT Plus: Trump is getting more credit than Biden for efforts to lower drug prices
Politics Politics March 13, 2026 STAT Plus: White House says it’s ‘done’ with vaccines. MAHA begs to differ
Politics Politics March 12, 2026 STAT Plus: Congressional advisers call to rein in Medicare Advantage spending amid industry pressure
Health tech STAT Plus: A brain-computer interface allowed people with paralysis to type with their minds
Health tech Health tech March 16, 2026 STAT Plus: A brain-computer interface allowed people with paralysis to type with their minds
Health tech Health tech March 12, 2026 STAT Plus: The FDA is targeting telehealth marketing of GLP-1 drugs. Who’s prescribing them?
Health tech Health tech March 11, 2026 STAT Plus: AI agents are rapidly spreading in health care, but validation is lacking
In the Lab STAT Plus: Cancer cells can ‘barf’ proteins onto their cell surface. That may create new targets for immunotherapies
In the Lab In the Lab March 12, 2026 STAT Plus: Cancer cells can ‘barf’ proteins onto their cell surface. That may create new targets for immunotherapies
In the Lab In the Lab February 20, 2026 With federal research funding uncertain, states debate new science initiatives
In the Lab In the Lab February 11, 2026 Students, faculty mystified as NSF turns back applications for prestigious fellowship program
Hospitals Hospitals March 13, 2026 STAT Plus: Leapfrog Group’s legal defeat underscores challenges of rating hospital quality
Hospitals Hospitals March 10, 2026 STAT Plus: After fight over cancer clinicians, Dana-Farber and Brigham are playing nice again
Hospitals Hospitals February 16, 2026 STAT Plus: Breakup between Brigham and Dana-Farber is getting messier fast
Insurance Insurance February 16, 2026 STAT Plus: Medicare Advantage growth dwindles for a second straight year
Insurance Insurance February 9, 2026 STAT Plus: Federal government turns to fresher data to rein in Medicare Advantage upcoding
Insurance Insurance January 12, 2026 STAT Plus: UnitedHealth has turned Medicare Advantage coding into ‘profit-centered strategy,’ Senate report finds